Learn more about remote inspections, FDA inspection training and begin preparing now for next year’s FDA remote inspections.
“Physical inspections, especially when unannounced, are one of FDA’s most important tools to ensure drug safety and quality.”
REPORT 117 (2021): AGRICULTURE, RURAL DEVELOPMENT, FOOD AND DRUG ADMINISTRATION, AND RELATED AGENCIES APPROPRIATIONS BILL
There will be a live demo of the world’s first multi-party immersive remote presence service by Avatour, as well as a breakdown of the U.S. House Appropriations Committee recently submitted an increase in budget for the Food and Drug Administration (FDA), including new funding for increased on-site inspections during 2022 and beyond.
Earlier reports also documented the incremental funding may be utilized for additional headcount to support the return to a normal rate of unannounced in-person FDA inspection events. International markets, including India and China, have also been mentioned as regions of interest due to previous 2020 travel complications due to the global COVID-19 pandemic.
In this webinar you will learn more about:
- How the FDA will utilize remote inspections in the future based on these changes
- Proactive companies who set compliance training exercises for their FDA inspection teams
- Considerations for revising standard operating procedures based on virtual compliance
- Virtual Audit Solutions for conducting training inspections similar to an FDA Audit
- Take a virtual tour of the fastest growing remote inspections technology, Avatour
- Best practices for partnering with the FDA during an unannounced inspection
